Talking the Cure by Hogan Lovells

About Talking the Cure by Hogan Lovells

Hogan Lovells Calwalader is always thinking about how to conquer and foresee the most significant industry issues facing our clients. Hear first-hand from our lawyers around the world on significant developments in the Life Sciences & Health Care sector and why they are so passionate about the industry. We unpack new and exciting industry trends and bring you more outside perspectives to keep you ahead of the curve.

Publisher

Hogan Lovells Cadwalader

Category

business

Language

en

Explicit

No

First episode

12 Oct 2020

Latest episode

20 Oct 2025

Latest episodes

57 episodes in the feed.

1. 

   20 Oct 2025

   It’s a Brave New World: Pharma ad/promo enforcement is changing in the U.S. and Europe, and companies should, too

   FDA’s recent splash of 100+ enforcement letters objecting to drug advertising looks like a trend, not a blip.  And although the UK and EU prohibit DTC ads for Rx drugs, there are new efforts creating risk for pharma companies, even if they’re not the main focus.  In this episode of Talking the Cure, host Phil Katz is joined by Heidi Gertner, Sally Gu, and Bonella Ramsay to unpack what’s happening and what it means pharma companies should be thinking about, and steps they should be taking now to mitigate current – and future – risks.

2. 

   22 Sept 2025

   The future of drug pricing: IRA, MFN, and tariff pressures explained

   In this episode of Talking the Cure, Hogan Lovells partners Phil Katz, Alice Valder Curren, and Jane Summerfield discuss the evolving landscape of pharmaceutical pricing, particularly legislative and administrative changes in the United States and their implications in Europe. The discussion includes the Inflation Reduction Act (IRA) in the U.S., Most Favored Nations (MFN) pricing policies, and the impact of tariffs on drug prices and supply chains.

3. 

   29 Jul 2025

   AI at the crossroads: Global developments shaping life sciences

   In this episode of Talking the Cure, Hogan Lovells partners Phil Katz, Melissa Bianchi, and Jodi Scott explore how artificial intelligence is transforming the pharmaceutical, biotech, and medical device industries. From AI-driven clinical trials and diagnostic tools to regulatory challenges and global compliance complexities, the discussion dives deep into both the promise and the pitfalls of integrating AI in health care. Tune in to hear how industry leaders are navigating this fast-evolving space – and what companies need to know to stay ahead.

Reach and audience

Public platform figures. Ratings count people who left a rating, not total listeners.

Spotify

5.0 / 5

1 ratings

Podcast Authority Score: 22 / 100

A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.

Quality

13

Social presence

0

YouTube

0

Engagement

75

Contact Talking the Cure by Hogan Lovells

Guest appearances

Does not typically book guests

Based on episode analysis; this does not confirm that the show is currently accepting guests.